Autolus Therapeutics Plc (AUTL)
1.60
-0.12
(-6.98%)
USD |
NASDAQ |
Oct 16, 16:00
1.59
-0.01
(-0.62%)
After-Hours: 20:00
Autolus Therapeutics Net Income (TTM) : -279.49M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -279.49M |
| March 31, 2026 | -288.81M |
| December 31, 2025 | -287.50M |
| September 30, 2025 | -224.65M |
| June 30, 2025 | -228.12M |
| March 31, 2025 | -237.88M |
| December 31, 2024 | -220.41M |
| September 30, 2024 | -270.23M |
| June 30, 2024 | -233.71M |
| March 31, 2024 | -221.16M |
| December 31, 2023 | -208.64M |
| September 30, 2023 | -158.62M |
| June 30, 2023 | -155.81M |
| March 31, 2023 | -152.15M |
| Date | Value |
|---|---|
| December 31, 2022 | -149.04M |
| September 30, 2022 | -163.55M |
| June 30, 2022 | -154.78M |
| March 31, 2022 | -145.89M |
| December 31, 2021 | -142.10M |
| September 30, 2021 | -143.29M |
| June 30, 2021 | -146.62M |
| March 31, 2021 | -145.49M |
| December 31, 2020 | -142.09M |
| September 30, 2020 | -140.18M |
| June 30, 2020 | -130.11M |
| March 31, 2020 | -126.54M |
| December 31, 2019 | -123.85M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Bicycle Therapeutics Plc | -190.00M |
| Biodexa Pharmaceuticals Plc | -5.93M |
| argenx SE | 1.714B |
| Mereo BioPharma Group Plc | -28.05M |
| Evaxion AS | -8.683M |